Cited by 242Clostridium difficile and Clostridium perfringens researchGut microbiota and healthBacterial Identification and Susceptibility Testing

The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.

Inhibition of spore germination, growth, and toxin activity of clinically relevant C. difficile strains by gut microbiota derived secondary bile acids

Open access

Thanissery, Rajani, Winston, Jenessa A., Theriot, Casey M.·2017·Anaerobe

DOI 10.1016/j.anaerobe.2017.03.004PMC PMC5466893

Open this paper in CoChat — free account

Abstract

The changing epidemiology of Clostridium difficile infection over the past decades presents a significant challenge in the management of C. difficile associated diseases. The gastrointestinal tract microbiota provides colonization resistance against C. difficile, and growing evidence suggests that gut microbial derived secondary bile acids (SBAs) play a role. We hypothesized that the C. difficile life cycle; spore germination and outgrowth, growth, and toxin production, of strains that vary by age and ribotype will differ in their sensitivity to SBAs. C. difficile strains R20291 and CD196 (ribotype 027), M68 and CF5 (017), 630 (012), BI9 (001) and M120 (078) were used to define taurocholate (TCA) mediated spore germination and outgrowth, growth, and toxin activity in the absence and presence of gut microbial derived SBAs (deoxycholate, isodeoxycholate, lithocholate, isolithocholate, ursodeoxycholate, ω-muricholate, and hyodeoxycholate) found in the human and mouse large intestine. C. difficile strains varied in their rates of germination, growth kinetics, and toxin activity without the addition of SBAs. C. difficile M120, a highly divergent strain, had robust germination, growth, but significantly lower toxin activity compared to other strains. Many SBAs were able to inhibit TCA mediated spore germination and outgrowth, growth, and toxin activity in a dose dependent manner, but the level of inhibition and resistance varied across all strains and ribotypes. This study illustrates how clinically relevant C. difficile strains can have different responses when exposed to SBAs present in the gastrointestinal tract.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.anaerobe.2017.03.004

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Bile salt biotransformations by human intestinal bacteria
Ridlon, J. M., Kang, D.-J., & Hylemon, P. B. (2006) · Journal of Lipid Research · doi:10.1194/jlr.r500013-jlr200 · Cited by 2,829
Burden of Clostridium difficile Infection in the United States
Lessa, F. C., Mu, Y., Bamberg, W. M., Beldavs, Z. G., Dumyati, G. K., Dunn, J. R., Farley, M. M., Holzbauer, S. M., Meek, J. I., Phipps, E. C., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1408913 · Cited by 2,641
Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist
Sayin, S. I., Wahlström, A., Felin, J., Jäntti, S., Marschall, H.-U., Bamberg, K., Angelin, B., Hyötyläinen, T., Orešič, M., & Bäckhed, F. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.01.003 · Cited by 2,331
The Enzymes, Regulation, and Genetics of Bile Acid Synthesis
Russell, D. W. (2003) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.72.121801.161712 · Cited by 2,069
An Epidemic, Toxin Gene–Variant Strain of Clostridium difficile
McDonald, L. C., Killgore, G., Thompson, A. D., Owens, R. C., Kazakova, S. V., Sambol, S. P., Johnson, S., & Gerding, D. N. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051590 · Cited by 2,020
Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile
Buffie, C. G., Bucci, V., Stein, R. R., McKenney, P. T., Ling, L., Gobourne, A., No, D., Liu, H., Kinnebrew, M., Viale, A., et al. (2015) · Nature · doi:10.1038/nature13828 · Cited by 1,872
Bile acids: regulation of synthesis
Chiang, J. Y. L. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r900010-jlr200 · Cited by 1,515
Clostridium difficile Infection
Leffler, D. A., & LaMont, J. T. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1403772 · Cited by 1,501
Clostridium difficile infection: new developments in epidemiology and pathogenesis
Rupnik, M., Wilcox, M. H., & Gerding, D. N. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2164 · Cited by 1,380 · cited 1×
“Other PCR ribotypes such as 001, 053, and 106 have also been associated with outbreaks and severe cases [6].”
Background
Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection
Theriot, C. M., Koenigsknecht, M. J., Carlson, P. E., Hatton, G. E., Nelson, A. M., Li, B., Huffnagle, G. B., Z. Li, J., & Young, V. B. (2014) · Nature Communications · doi:10.1038/ncomms4114 · Cited by 974
Self-citation

Show all 45 references

Sorted by citations

Bile acids and the gut microbiota: metabolic interactions and impacts on disease
Collins, S. L., Stine, J. G., Bisanz, J. E., Okafor, C. D., & Patterson, A. D. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00805-x · Cited by 1,214
Clostridium difficile infection: review
Czepiel, J., Dróżdż, M., Pituch, H. M., Kuijper, E. J., Perucki, W. H., Mielimonka, A., Goldman, S., Wultańska, D., Garlicki, A., & Biesiada, G. (2019) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-019-03539-6 · Cited by 770
Novel bile acid biosynthetic pathways are enriched in the microbiome of centenarians
Sato, Y., Atarashi, K., Plichta, D. R., Arai, Y., Sasajima, S., Kearney, S. M., Suda, W., Takeshita, K., Sasaki, T., Okamoto, S., et al. (2021) · Nature · doi:10.1038/s41586-021-03832-5 · Cited by 632
Antimicrobial Properties of Chitosan and Chitosan Derivatives in the Treatment of Enteric Infections
Yan, D., Li, Y., Liu, Y., Li, N., Zhang, X., & Yan, C. (2021) · Molecules · doi:10.3390/molecules26237136 · Cited by 656
Gut Microbiota and Colonization Resistance against Bacterial Enteric Infection
Ducarmon, Q. R., Zwittink, R. D., Hornung, B. V. H., van Schaik, W., Young, V. B., & Kuijper, E. J. (2019) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00007-19 · Cited by 566
Bile acid metabolism and signaling, the microbiota, and metabolic disease
Cai, J., Rimal, B., Jiang, C., Chiang, J. Y. L., & Patterson, A. D. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108238 · Cited by 529
The role of the microbiota in infectious diseases
Libertucci, J., & Young, V. B. (2018) · Nature Microbiology · doi:10.1038/s41564-018-0278-4 · Cited by 370
Clinical Application and Potential of Fecal Microbiota Transplantation
Ooijevaar, R. E., Terveer, E. M., Verspaget, H. W., Kuijper, E. J., & Keller, J. J. (2018) · Annual Review of Medicine · doi:10.1146/annurev-med-111717-122956 · Cited by 348
Mining the microbiota for microbial and metabolite-based immunotherapies
Skelly, A. N., Sato, Y., Kearney, S., & Honda, K. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0144-5 · Cited by 306
Mechanism of the Gut Microbiota Colonization Resistance and Enteric Pathogen Infection
Khan, I., Bai, Y., Zha, L., Ullah, N., Ullah, H., Shah, S. R. H., Sun, H., & Zhang, C. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.716299 · Cited by 291
Bile salt hydrolases: Gatekeepers of bile acid metabolism and host-microbiome crosstalk in the gastrointestinal tract
Foley, M. H., O’Flaherty, S., Barrangou, R., & Theriot, C. M. (2019) · PLOS Pathogens · doi:10.1371/journal.ppat.1007581 · Cited by 271
Self-citation
Microbial bile salt hydrolases mediate the efficacy of faecal microbiota transplant in the treatment of recurrent Clostridioides difficile infection
Mullish, B. H., McDonald, J. A. K., Pechlivanis, A., Allegretti, J. R., Kao, D., Barker, G. F., Kapila, D., Petrof, E. O., Joyce, S. A., Gahan, C. G. M., et al. (2019) · Gut · doi:10.1136/gutjnl-2018-317842 · Cited by 268
Microbiome-based interventions to modulate gut ecology and the immune system
Hitch, T. C. A., Hall, L. J., Walsh, S. K., Leventhal, G. E., Slack, E. M. C., de Wouters, T., Walter, J., & Clavel, T. (2022) · Mucosal Immunology · doi:10.1038/s41385-022-00564-1 · Cited by 268
Bile Acids Are Substrates for Amine N-Acyl Transferase Activity by Bile Salt Hydrolase
Patterson, A., Rimal, B., Collins, S., Granda, M., Koo, I., Solanka, S., Hoque, N., Gentry, E., Yan, T., Bisanz, J., et al. (2022) · doi:10.21203/rs.3.rs-2050120/v1 · Cited by 252
Bacteroides and related species: The keystone taxa of the human gut microbiota
Shin, J. H., Tillotson, G., MacKenzie, T. N., Warren, C. A., Wexler, H. M., & Goldstein, E. J. C. (2024) · Anaerobe · doi:10.1016/j.anaerobe.2024.102819 · Cited by 254
In Vivo Targeting of Clostridioides difficile Using Phage-Delivered CRISPR-Cas3 Antimicrobials
Selle, K., Fletcher, J. R., Tuson, H. H., Schmitt, D. S., McMillan, L. J., Vridhambal, G. S., Rivera, A. J., Montgomery, S. A., Fortier, L., Barrangou, R., et al. (2020) · mBio · doi:10.1128/mbio.00019-20 · Cited by 242
Self-citation
The changing metabolic landscape of bile acids – keys to metabolism and immune regulation
Mohanty, I., Allaband, C., Mannochio-Russo, H., Abiead, Y. E., Hagey, L. R., Knight, R. D., & Dorrestein, P. C. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-024-00914-3 · Cited by 236
Inter-individual Recovery of the Microbiota and Metabolome Over Time Following Fecal Microbiota Transplantation in Patients with Recurrent Clostridium difficile Infection
Seekatz, A. M., Theriot, C. M., Rao, K. K., Chang, Y., Freeman, A. E., Kao, J. Y., & Young, V. B. (2017) · Anaerobe · doi:10.1016/j.anaerobe.2018.04.001 · Cited by 197
Self-citation
Inhibiting Growth of Clostridioides difficile by Restoring Valerate, Produced by the Intestinal Microbiota
McDonald, J. A. K., Mullish, B. H., Pechlivanis, A., Liu, Z., Brignardello, J., Kao, D. H., Holmes, E. C., Li, J. V., Clarke, T. B., Thursz, M. R., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.07.014 · Cited by 200
Bile salt hydrolases shape the bile acid landscape and restrict Clostridioides difficile growth in the murine gut
Foley, M. H., Walker, M. E., Stewart, A. K., O’Flaherty, S., Gentry, E. C., Patel, S., Beaty, V. V., Allen, G., Pan, M., Simpson, J. B., et al. (2023) · Nature Microbiology · doi:10.1038/s41564-023-01337-7 · Cited by 181
Self-citation
Clostridioides difficile infection: history, epidemiology, risk factors, prevention, clinical manifestations, treatment, and future options
Bella, S. D., Sanson, G., Monticelli, J., Zerbato, V., Principe, L., Giuffrè, M., Pipitone, G., & Luzzati, R. (2024) · Clinical Microbiology Reviews · doi:10.1128/cmr.00135-23 · Cited by 202
Clostridioides difficile Biology: Sporulation, Germination, and Corresponding Therapies for C. difficile Infection
Zhu, D., Sorg, J. A., & Sun, X. (2018) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2018.00029 · Cited by 168
How bile acids and the microbiota interact to shape host immunity
Lee, M. H., Nuccio, S.-P., Mohanty, I., Hagey, L. R., Dorrestein, P. C., Chu, H., & Raffatellu, M. (2024) · Nature Reviews Immunology · doi:10.1038/s41577-024-01057-x · Cited by 143
Colonization of the live biotherapeutic product VE303 and modulation of the microbiota and metabolites in healthy volunteers
Dsouza, M., Menon, R., Crossette, E. M., Bhattarai, S. K., Schneider, J., Kim, Y., Reddy, S., Caballero, S., Felix, C. R., Cornacchione, L. P., et al. (2022) · Cell Host & Microbe · doi:10.1016/j.chom.2022.03.016 · Cited by 142
Saccharomyces boulardii CNCM I-745: A Non-bacterial Microorganism Used as Probiotic Agent in Supporting Treatment of Selected Diseases
Kaźmierczak-Siedlecka, K., Ruszkowski, J., Fic, M., Folwarski, M., & Makarewicz, W. (2020) · Current Microbiology · doi:10.1007/s00284-020-02053-9 · Cited by 127
In vivo commensal control of Clostridioides difficile virulence
Girinathan, B. P., DiBenedetto, N., Worley, J. N., Peltier, J., Arrieta-Ortiz, M. L., Immanuel, S. R. C., Lavin, R., Delaney, M. L., Cummins, C. K., Hoffman, M., et al. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.09.007 · Cited by 114
A microbiota-generated bile salt induces biofilm formation in Clostridium difficile
Dubois, T., Tremblay, Y. D. N., Hamiot, A., Martin‐Verstraete, I., Deschamps, J., Monot, M., Briandet, R., & Dupuy, B. (2019) · npj Biofilms and Microbiomes · doi:10.1038/s41522-019-0087-4 · Cited by 124
Shifts in the Gut Metabolome and Clostridium difficile Transcriptome throughout Colonization and Infection in a Mouse Model
Fletcher, J. R., Erwin, S., Lanzas, C., & Theriot, C. M. (2018) · mSphere · doi:10.1128/msphere.00089-18 · Cited by 104
Self-citation
Clostridioides difficile: diagnosis and treatments
Guery, B. P., Galpérine, T., & Barbut, F. (2019) · BMJ · doi:10.1136/bmj.l4609 · Cited by 117
Mechanistic Insights in the Success of Fecal Microbiota Transplants for the Treatment of Clostridium difficile Infections
Baktash, A., Terveer, E. M., Zwittink, R. D., Hornung, B., Corver, J., Kuijper, E. J., & Smits, W. K. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01242 · Cited by 112
Role of the gut microbiota in nutrient competition and protection against intestinal pathogen colonization
Horrocks, V., King, O. G., Yip, A. Y. G., Marques, I. M., & McDonald, J. A. K. (2023) · Microbiology · doi:10.1099/mic.0.001377 · Cited by 104
Bile acid-independent protection against Clostridioides difficile infection
Aguirre, A. M., Yalçınkaya, N., Wu, Q., Swennes, A. G., Tessier, M. E. M., Roberts, P., Miyajima, F., Savidge, T., & Sorg, J. A. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1010015 · Cited by 95
Metabolomic networks connect host-microbiome processes to human Clostridioides difficile infections
Robinson, J. I., Weir, W. H., Crowley, J. R., Hink, T., Reske, K. A., Kwon, J. H., Burnham, C. D., Dubberke, E. R., Mucha, P. J., & Henderson, J. P. (2019) · Journal of Clinical Investigation · doi:10.1172/jci126905 · Cited by 91
Ursodeoxycholic Acid (UDCA) Mitigates the Host Inflammatory Response during Clostridioides difficile Infection by Altering Gut Bile Acids
Winston, J. A., Rivera, A. J., Cai, J., Thanissery, R., Montgomery, S. A., Patterson, A. D., & Theriot, C. M. (2020) · Infection and Immunity · doi:10.1128/iai.00045-20 · Cited by 91
Self-citation
Host immunity modulates the efficacy of microbiota transplantation for treatment of Clostridioides difficile infection
Littmann, E. R., Lee, J.-J., Denny, J. E., Alam, Z., Maslanka, J. R., Zarin, I., Matsuda, R., Carter, R. A., Susac, B., Saffern, M. S., et al. (2021) · Nature Communications · doi:10.1038/s41467-020-20793-x · Cited by 88
Bile salt hydrolase: The complexity behind its mechanism in relation to lowering-cholesterol lactobacilli probiotics
Agolino, G., Pino, A., Vaccalluzzo, A., Cristofolini, M., Solieri, L., Caggia, C., & Randazzo, C. L. (2024) · Journal of Functional Foods · doi:10.1016/j.jff.2024.106357 · Cited by 99
The functions of gut microbiota-mediated bile acid metabolism in intestinal immunity
He, Y., Shaoyong, W., Chen, Y., Li, M., Gan, Y., Sun, L., Liu, Y., Wang, Y., & Jin, M. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.05.015 · Cited by 107
Beneficial effects of fecal microbiota transplantation in recurrent Clostridioides difficile infection
Yadegar, A., Pakpour, S., Ibrahim, F. F., Nabavi-Rad, A., Cook, L. E., Walter, J., Seekatz, A. M., Wong, K., Monaghan, T. M., & Kao, D. H. (2023) · Cell Host & Microbe · doi:10.1016/j.chom.2023.03.019 · Cited by 90
Adjunctive fecal microbiota transplantation in supportive oncology: Emerging indications and considerations in immunocompromised patients
Wardill, H. R., Secombe, K. R., Bryant, R. V., Hazenberg, M. D., & Costello, S. P. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.03.070 · Cited by 87
Multi-omic Analysis of the Interaction between Clostridioides difficile Infection and Pediatric Inflammatory Bowel Disease
Bushman, F. D., Conrad, M. A., Ren, Y., Zhao, C., Gu, C., Petucci, C. J., Kim, M., Abbas, A. A., Downes, K. J., Devas, N., et al. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.07.020 · Cited by 82
Clostridioides difficile Spore Formation and Germination: New Insights and Opportunities for Intervention
Shen, A. (2020) · Annual Review of Microbiology · doi:10.1146/annurev-micro-011320-011321 · Cited by 83
Intestinal bile acids directly modulate the structure and function of C. difficile TcdB toxin
Tam, J., Icho, S., Utama, E., Orrell, K. E., Gómez‐Biagi, R. F., Theriot, C. M., Kroh, H. K., Rutherford, S. A., Lacy, D. B., & Melnyk, R. A. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1916965117 · Cited by 81
Self-citation
Capturing the environment of the Clostridioides difficile infection cycle
Schnizlein, M. K., & Young, V. B. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-022-00610-0 · Cited by 63
Novel therapies and preventative strategies for primary and recurrent Clostridium difficile infections
Dieterle, M. G., Rao, K. K., & Young, V. B. (2018) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13958 · Cited by 62
Mechanisms of Colonization Resistance Against Clostridioides difficile
Pike, C. M., & Theriot, C. M. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa408 · Cited by 66
Self-citation
Novel Developments on Stimuli-Responsive Probiotic Encapsulates: From Smart Hydrogels to Nanostructured Platforms
Garcia-Brand, A. J., Quezada, V., González, C., Bolaños-Barbosa, A. D., Cruz, J. C., & Reyes, L. H. (2022) · Fermentation · doi:10.3390/fermentation8030117 · Cited by 60
The gut microbiota-bile acid axis: a crucial regulator of immune function and metabolic health
Tyagi, A., & Kumar, V. (2025) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-025-04395-7 · Cited by 68
The contribution of bile acid metabolism to the pathogenesis of Clostridioides difficile infection
Mullish, B. H., & Allegretti, J. R. (2021) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848211017725 · Cited by 61
The bile acid-gut microbiota axis: A central hub for physiological regulation and a novel therapeutic target for metabolic diseases
Zhao, M., Jiafeng, Z., Yang, H., Ouyang, Z., Lv, C., Geng, Z., & Zhao, J. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118182 · Cited by 69
Effective fecal microbiota transplantation for recurrent Clostridioides difficile infection in humans is associated with increased signalling in the bile acid-farnesoid X receptor-fibroblast growth factor pathway
Monaghan, T. M., Mullish, B. H., Patterson, J., Wong, G. K., Marchesi, J. R., Xu, H., Jilani, T. A., & Kao, D. H. (2018) · Gut Microbes · doi:10.1080/19490976.2018.1506667 · Cited by 59
Microbe–microbe interactions during Clostridioides difficile infection
Abbas, A. A., & Zackular, J. P. (2020) · Current Opinion in Microbiology · doi:10.1016/j.mib.2020.01.016 · Cited by 58
A Revised Understanding of Clostridioides difficile Spore Germination
Lawler, A. J., Lambert, P. A., & Worthington, T. (2020) · Trends in Microbiology · doi:10.1016/j.tim.2020.03.004 · Cited by 56
Antibiotic Treatments for Clostridium difficile Infection Are Associated with Distinct Bacterial and Fungal Community Structures
Lamendella, R., Wright, J., Hackman, J., McLimans, C. J., Toole, D. R., Rubio, W. B., Drucker, R., Wong, H. T., Sabey, K. A., Hegarty, J. P., et al. (2018) · mSphere · doi:10.1128/msphere.00572-17 · Cited by 54
Strain-Dependent Inhibition of Clostridioides difficile by Commensal Clostridia Carrying the Bile Acid-Inducible ( bai ) Operon
Reed, A. D., Nethery, M. A., Stewart, A. K., Barrangou, R., & Theriot, C. M. (2020) · Journal of Bacteriology · doi:10.1128/jb.00039-20 · Cited by 49
Self-citation
The Gut Bacterial Community Potentiates Clostridioides difficile Infection Severity
Lesniak, N. A., Schubert, A. M., Flynn, K. J., Leslie, J. L., Sinani, H., Bergin, I. L., Young, V. B., & Schloss, P. D. (2022) · mBio · doi:10.1128/mbio.01183-22 · Cited by 50
Akkermansia muciniphila Ameliorates Clostridioides difficile Infection in Mice by Modulating the Intestinal Microbiome and Metabolites
Wu, Z., Xu, Q., Gu, S., Chen, Y., Lv, L., Zheng, B., Wang, Q., Wang, K., Wang, S., Xia, J., et al. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.841920 · Cited by 49
How Food Affects Colonization Resistance Against Enteropathogenic Bacteria
Kreuzer, M., & Hardt, W. (2020) · Annual Review of Microbiology · doi:10.1146/annurev-micro-020420-013457 · Cited by 45
BaiCD gene cluster abundance is negatively correlated with Clostridium difficile infection
Solbach, P., Chhatwal, P., Woltemate, S., Tacconelli, E., Buhl, M. E. J., Gerhard, M., Thoeringer, C. K., Vehreschild, M. J. G. T., Jazmati, N., Rupp, J., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0196977 · Cited by 48
Clostridioides difficile and Gut Microbiota: From Colonization to Infection and Treatment
Spigaglia, P. (2024) · Pathogens · doi:10.3390/pathogens13080646 · Cited by 53
The characteristics analysis of intestinal microecology on cerebral infarction patients and its correlation with apolipoprotein E
Wang, W., Xu, L., Yao, X., Cheng, X., & Zhu, Y. (2018) · Medicine · doi:10.1097/md.0000000000012805 · Cited by 45
Interplay between Bile Acids and Intestinal Microbiota: Regulatory Mechanisms and Therapeutic Potential for Infections
Li, W., Chen, H., & Tang, J. (2024) · Pathogens · doi:10.3390/pathogens13080702 · Cited by 49
The Great ESKAPE: Exploring the Crossroads of Bile and Antibiotic Resistance in Bacterial Pathogens
Gipson, K. S., Nickerson, K. P., Drenkard, E., Llanos‐Chea, A., Dogiparthi, S. K., Lanter, B. B., Hibbler, R. M., Yonker, L. M., Hurley, B. P., & Faherty, C. S. (2020) · Infection and Immunity · doi:10.1128/iai.00865-19 · Cited by 44
Probiotics: insights and new opportunities for Clostridioides difficile intervention
Pal, R., Athamneh, A. I. M., Deshpande, R., Ramirez, J. A. R., Adu, K. T., Muthuirulan, P., Pawar, S., Biazzo, M., Apidianakis, Y., Sundekilde, U. K., et al. (2022) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2022.2072705 · Cited by 44
Contribution of Inhibitory Metabolites and Competition for Nutrients to Colonization Resistance against Clostridioides difficile by Commensal Clostridium
Reed, A. D., & Theriot, C. M. (2021) · Microorganisms · doi:10.3390/microorganisms9020371 · Cited by 39
Self-citation
Bioengineered Probiotics: Synthetic Biology Can Provide Live Cell Therapeutics for the Treatment of Foodborne Diseases
Cruz, K. C. P., Enekegho, L. O., & Stuart, D. T. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.890479 · Cited by 45
Correlation between Targeted qPCR Assays and Untargeted DNA Shotgun Metagenomic Sequencing for Assessing the Fecal Microbiota in Dogs
Sung, C., Pilla, R., Chen, C.-C., Ishii, P. E., Toresson, L., Allenspach‐Jorn, K., Jergens, A. E., Summers, S., Swanson, K. S., Volk, H. A., et al. (2023) · Animals · doi:10.3390/ani13162597 · Cited by 52
Developmental stages in microbiota, bile acids, and clostridial species in healthy puppies
Blake, A. B., Cigarroa, A., Klein, H. L., Khattab, M. R., Keating, T., Coevering, P. V. D., Lidbury, J. A., Steiner, J. M., & Suchodolski, J. S. (2020) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.15928 · Cited by 41
Effect of lotus seed resistant starch on small intestinal flora and bile acids in hyperlipidemic rats
Lei, S., He, S., Li, X., Zheng, B., Zhang, Y., & Zeng, H. (2022) · Food Chemistry · doi:10.1016/j.foodchem.2022.134599 · Cited by 41
Gut associated metabolites and their roles in Clostridioides difficile pathogenesis
Aguirre, A. M., & Sorg, J. A. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2094672 · Cited by 41
A Randomized, Double-Blind, Phase 3 Safety and Efficacy Study of Ridinilazole Versus Vancomycin for Treatment of Clostridioides difficile Infection: Clinical Outcomes With Microbiome and Metabolome Correlates of Response
Okhuysen, P. C., Ramesh, M. S., Louie, T., Kiknadze, N., Torre‐Cisneros, J., de Oliveira, C. M., Steenkiste, C. V., Stychneuskaya, A., Garey, K. W., Garcia‐Diaz, J., et al. (2024) · Clinical Infectious Diseases · doi:10.1093/cid/ciad792 · Cited by 39
Dietary Xanthan Gum Alters Antibiotic Efficacy against the Murine Gut Microbiota and Attenuates Clostridioides difficile Colonization
Schnizlein, M. K., Vendrov, K. C., Edwards, S. J., Martens, E. C., & Young, V. B. (2020) · mSphere · doi:10.1128/msphere.00708-19 · Cited by 41
Ridinilazole, a narrow spectrum antibiotic for treatment of Clostridioides difficile infection, enhances preservation of microbiota-dependent bile acids
Qian, X., Yanagi, K., Kane, A. V., Alden, N., Lei, M., Snydman, D. R., Vickers, R. J., Lee, K., & Thorpe, C. M. (2020) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00046.2020 · Cited by 40
Obeticholic acid ameliorates severity of Clostridioides difficile infection in high fat diet-induced obese mice
Jose, S., Mukherjee, A., Horrigan, O., Setchell, K. D. R., Zhang, W., Moreno‐Fernandez, M. E., Andersen, H. M., Sharma, D., Haslam, D. B., Divanovic, S., et al. (2020) · Mucosal Immunology · doi:10.1038/s41385-020-00338-7 · Cited by 40
Metagenomic, metabolomic, and lipidomic shifts associated with fecal microbiota transplantation for recurrent Clostridioides difficile infection
McMillan, A. S., Zhang, G., Dougherty, M., McGill, S., Gulati, A., Baker, E. S., & Theriot, C. M. (2024) · mSphere · doi:10.1128/msphere.00706-24 · Cited by 40
Self-citation
In sickness and health: Effects of gut microbial metabolites on human physiology
Glowacki, R. W. P., & Martens, E. C. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008370 · Cited by 40
Gut microbes improve prognosis of Klebsiella pneumoniae pulmonary infection through the lung-gut axis
Tang, Y., Chen, L., Yang, J., Zhang, S., Jin, J., & Yao, W. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1392376 · Cited by 44
Protection from Lethal Clostridioides difficile Infection via Intraspecies Competition for Cogerminant
Leslie, J. L., Jenior, M. L., Vendrov, K. C., Standke, A. K., Barron, M. R., O’Brien, T. J., Unverdorben, L. V., Thaprawat, P., Bergin, I. L., Schloss, P. D., et al. (2021) · mBio · doi:10.1128/mbio.00522-21 · Cited by 35
Bile acids impact the microbiota, host, and C. difficile dynamics providing insight into mechanisms of efficacy of FMTs and microbiota-focused therapeutics
McMillan, A. S., & Theriot, C. M. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2393766 · Cited by 41
Self-citation
Microbiota-derived bile acid metabolic enzymes and their impacts on host health
Ma, H., Wang, K., & Jiang, C. (2025) · Cell Insight · doi:10.1016/j.cellin.2025.100265 · Cited by 37
The Route to Palatable Fecal Microbiota Transplantation
Fadda, H. M. (2020) · AAPS PharmSciTech · doi:10.1208/s12249-020-1637-z · Cited by 36
Multi-omic profiling a defined bacterial consortium for treatment of recurrent Clostridioides difficile infection
Menon, R., Bhattarai, S. K., Crossette, E. M., Prince, A., Olle, B., Silber, J. L., Bucci, V., Faith, J. J., & Norman, J. M. (2025) · Nature Medicine · doi:10.1038/s41591-024-03337-4 · Cited by 35
The Stickland Reaction Precursor trans -4-Hydroxy- l -Proline Differentially Impacts the Metabolism of Clostridioides difficile and Commensal Clostridia
Reed, A. D., Fletcher, J. R., Huang, Y. Y., Thanissery, R., Rivera, A. J., Parsons, R., Stewart, A. K., Kountz, D. J., Shen, A., Balskus, E. P., et al. (2022) · mSphere · doi:10.1128/msphere.00926-21 · Cited by 31
Self-citation
Butyrate Protects against Clostridium difficile Infection by Regulating Bile Acid Metabolism
Wang, S., Xiang, L., Li, F., Deng, W., Lv, P., & Chen, Y. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.04479-22 · Cited by 32
Antibiotics Associated With Clostridium difficile Infection
Rafey, A., Jahan, S., Farooq, U., Akhtar, F., Irshad, M., Nizamuddin, S., & Parveen, A. (2023) · Cureus · doi:10.7759/cureus.39029 · Cited by 30
The Relationship Between the Microbiome and Antimicrobial Resistance
Nhu, N. T. Q., & Young, V. B. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad641 · Cited by 30
A Comparison of Currently Available and Investigational Fecal Microbiota Transplant Products for Recurrent Clostridioides difficile Infection
Wang, Y., Hunt, A., Danziger, L. H., & Drwiega, E. N. (2024) · Antibiotics · doi:10.3390/antibiotics13050436 · Cited by 29
The microbial-derived bile acid lithocholate and its epimers inhibit Clostridioides difficile growth and pathogenicity while sparing members of the gut microbiota
Kisthardt, S. C., Thanissery, R., Pike, C. M., Foley, M. H., & Theriot, C. M. (2023) · Journal of Bacteriology · doi:10.1128/jb.00180-23 · Cited by 29
Self-citation
Gut Microbiota–Gut Metabolites and Clostridioides difficile Infection: Approaching Sustainable Solutions for Therapy
Gurung, B., Stricklin, M. L., & Wang, S. (2024) · Metabolites · doi:10.3390/metabo14010074 · Cited by 28
Time‐limited diets and the gut microbiota in cardiometabolic disease
Ratiner, K., Shapiro, H., Goldenberg, K., & Elinav, E. (2022) · Journal of Diabetes · doi:10.1111/1753-0407.13288 · Cited by 27
Differential View on the Bile Acid Stress Response of Clostridioides difficile
Sievers, S., Metzendorf, N. G., Dittmann, S., Troitzsch, D., Gast, V., Tröger, S. M., Wolff, C., Zühlke, D., Hirschfeld, C., Schlüter, R., et al. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00258 · Cited by 26
Characterization of the gut microbiome of patients with Clostridioides difficile infection, patients with non–C. difficile diarrhea, and C. difficile–colonized patients
Vázquez‐Cuesta, S., Villar-Gómara, L., Lozano-García, N., Fernández, A. I., Olmedo, M., Alcalá, L., Marı́n, M., Muñóz, P., Bouza, E., & Reigadas, E. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1130701 · Cited by 26
Novel microbially transformed bile acids: Biosynthesis, structure, and function
Zhao, Q., Duan, Z., Lai, R., & Ma, P. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107775 · Cited by 26
Clearance of Clostridioides difficile Colonization Is Associated with Antibiotic-Specific Bacterial Changes
Lesniak, N. A., Schubert, A. M., Sinani, H., & Schloss, P. D. (2021) · mSphere · doi:10.1128/msphere.01238-20 · Cited by 26
A Multi-Factorial Observational Study on Sequential Fecal Microbiota Transplant in Patients with Medically Refractory Clostridioides difficile Infection
Monaghan, T. M., Duggal, N. A., Rosati, E., Griffin, R., Hughes, J., Roach, B., Yang, D. Y., Wang, C., Wong, K., Saxinger, L. M., et al. (2021) · Cells · doi:10.3390/cells10113234 · Cited by 23
Collaborative Metabolism: Gut Microbes Play a Key Role in Canine and Feline Bile Acid Metabolism
Rowe, J. C., & Winston, J. A. (2024) · Veterinary Sciences · doi:10.3390/vetsci11020094 · Cited by 26
Self-citation
Type 3 Immunity during Clostridioides difficile Infection: Too Much of a Good Thing?
Saleh, M. M., & Petri, W. A. (2019) · Infection and Immunity · doi:10.1128/iai.00306-19 · Cited by 23
The gut microbiota and host immunity synergistically orchestrate colonization resistance
Li, N., & Guo, X. (2026) · Gut Microbes · doi:10.1080/19490976.2025.2611545 · Cited by 26
Clostridioides difficile bile salt hydrolase activity has substrate specificity and affects biofilm formation
Aguirre, A. M., Adegbite, A. O., & Sorg, J. A. (2022) · npj Biofilms and Microbiomes · doi:10.1038/s41522-022-00358-0 · Cited by 24
A Small Molecule-Screening Pipeline to Evaluate the Therapeutic Potential of 2-Aminoimidazole Molecules Against Clostridium difficile
Thanissery, R., Zeng, D., Doyle, R. G., & Theriot, C. M. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01206 · Cited by 22
Self-citation
Multi-omics analysis of hospital-acquired diarrhoeal patients reveals biomarkers of enterococcal proliferation and Clostridioides difficile infection
Bosnjak, M., Karpe, A. V., Van, T. T. H., Kotsanas, D., Jenkin, G., Costello, S. P., Johanesen, P., Moore, R. J., Beale, D. J., Srikhanta, Y. N., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-43671-8 · Cited by 22

Authors: Thanissery, R., Winston, J. A., & Theriot, C. M.
Affiliations: North Carolina State University (US)
Corresponding author: Theriot, Casey M.
ORCID: Thanissery, Rajani
Winston, Jenessa A.
Theriot, Casey M.
Venue: Anaerobe
Publisher: Elsevier BV
Published: 2017-06
Volume: 45
Pages: 86-100
ISSN: 1075-9964 (ISSN-L)
DOI: 10.1016/j.anaerobe.2017.03.004
PMC: PMC5466893
OpenAlex: W2593518051
Cited by: 242
References: 45
Citations by year: 2026: 24 · 2025: 35 · 2024: 34 · 2023: 26 · 2022: 32 · 2021: 23 · 2020: 30 · 2019: 22 · 2018: 13 · 2017: 3
FWCI: 14.31
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Anaerobe (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: Ruth L. Kirschstein National Research Service (T32OD011130)
National Institutes of Health (R35GM119438 (CMT))
career development award in metabolomic (K01GM109236 (CMT))
Topics: Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Health Sciences › Medicine › Microbiology (medical) › Bacterial Identification and Susceptibility Testing
Keywords: Clostridium difficile, secondary bile acids, spore germination, toxin production, gut microbiota, colonization resistance, taurocholate, deoxycholate, ribotypes, strain differences, Clostridium difficile infection, growth kinetics
MeSH terms: Gastrointestinal Microbiome, Animals, Antibiosis, Anti-Bacterial Agents, Bacterial Toxins, Bile Acids and Salts, Humans, Spores, Bacterial, Clostridioides difficile, Gastrointestinal Tract, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Inhibition of spore germination, growth, and toxin activity of clinically relevant C. difficile strains by gut microbiota derived secondary bile acids

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks